L. Bosquet

发表

2008 French national guidelines for the treatment of venous thromboembolism in patients with cancer: report from the working group.

D. Farge, H. Lévesque, G. Meyer, 2010, Critical reviews in oncology/hematology.

SOR guidelines for the treatment of venous thromboembolism in patients with cancer : Report from the working group

D. Farge, H. Lévesque, G. Meyer, 2009 .

Direct oral anticoagulants as a new option in the treatment of venous thromboembolic disease in cancer patients

D. Farge-Bancel, P. Debourdeau, L. Florea, 2008 .

[2008 Standards, Options: recommendations for venous thromboembolic events (VTE) treatment and central venous catheter thrombosis (CVCT) management in cancer patients].

H. Lévesque, G. Meyer, P. Mismetti, 2008, Bulletin du cancer.

A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes

N. Girard, D. Planchard, P. Dubray-Longeras, 2021, Targeted Oncology.

Impact of immune checkpoint inhibitors on the management of locally advanced or metastatic non-small cell lung cancer in real-life practice in patients initiating treatment between 2015 and 2018 in France and Germany.

N. Girard, I. Durand-zaleski, J. Penrod, 2022, Lung cancer.

[2008 Standards, Options: Recommendations for venous thromboembolic events(VTE)treatment and central venous catheter thrombosis(CVCT) management in cancer patients].

H. Lévesque, G. Meyer, P. Mismetti, 2008, Journal des maladies vasculaires.

[Standards, Options: recommendations 2008; thromboembolic events treatment, prophylaxis and treatment of central venous catheter thrombosis in patients with cancer].

H. Lévesque, G. Meyer, P. Mismetti, 2008, Annales Francaise d'Anesthesie et de Reanimation.

Management of adult patients with cutaneous melanoma without distant metastasis. 2005 update of the French Standards, Options and Recommendations guidelines. Summary report.

J. Grob, B. Dréno, M. Avril, 2007, European journal of dermatology : EJD.

[Recommendations for venous thromboembolic events treatment and central venous catheter thrombosis management in cancer patients].

H. Lévesque, G. Meyer, P. Mismetti, 2009, Presse medicale.

[Clinical practice guideline: 2005 update of recommendations for the management of patients with cutaneous melanoma without distant metastases (summary report)].

J. Grob, B. Dréno, M. Avril, 2006, Bulletin du cancer.

An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations

J. Wolf, Jedelyn Cabrieto, Nicole Erdmann, 2023, Advances in Therapy.

[Synthesis bulletin of 2005 surveillance. Clinical practice recommendations: the use of PET-FDG in cancers of the breast, ovary and uterus].

E. Touboul, D. Vinatier, A. Hitzel, 2006, Bulletin du cancer.

Effectiveness of Nivolumab in Second-Line and Later in Patients with Advanced Non-Small Cell Lung Cancer in Real-Life Practice in France and Germany: Analysis of the ESME-AMLC and CRISP Cohorts

I. Durand-zaleski, J. Penrod, F. Cotté, 2022, Cancers.

Summary of the Standards, Options and Recommendations for the use of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose (FDP-PET scanning) in oncology (2002)

B. Chauffert, J. Talbot, A. Devillers, 2003, British Journal of Cancer.

Efficacy of chemotherapy according to BRCA status in patients with high-grade serous ovarian carcinoma at first platinum-sensitive relapse

P. Colombo, I. Ray-Coquard, A. Floquet, 2023, International Journal of Gynecological Cancer.